Tech Company Financing Transactions
BIND Therapeutics Funding Round
BIND Therapeutics, operating out of Cambridge, secured $16 million from Arch Venture Partners, Flagship Pioneering and Polaris Partners.
Transaction Overview
Company Name
Announced On
11/27/2007
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Series B
Investors
Proceeds Purpose
The proceeds of this financing will be used to advance BIND's preclinical product pipeline to clinical trials and expand its product development capabilities.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
325 Vassar St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
BIND Therapeutics is a venture backed biopharmaceutical company focused on engineering targeted therapeutics. BIND's technology was developed by world class laboratories at MIT and Harvard.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Hirsch
Chief Medical Officer
Hagop Youssoufian
VP - Bus. Development
Daniel Koerwer
VP - Bus. Development
Stephen Zale
VP - Finance
Chris Lindblom
VP - Regulatory Affairs
David Mantus
Browse more venture capital transactions:
Prev: 11/27/2007: Gigle Semiconductor venture capital transaction
Next: 11/27/2007: International Battery venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs